tradingkey.logo

Immunovant Inc <IMVT.OQ> expected to post a loss of 72 cents a share - Earnings Preview

ReutersMay 28, 2025 12:33 PM
  • Immunovant Inc IMVT.OQ IMVT.O is expected to show no change in quarterly revenue when it reports results on May 30 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Immunovant Inc is for a loss of 72 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Immunovant Inc is $51.00​, above​ its last closing price of $14.29. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.77

-0.75

-0.76

Missed

-1.4

Sep. 30 2024

-0.61

-0.60

-0.74

Missed

-23.9

Jun. 30 2024

-0.53

-0.53

-0.60

Missed

-13.8​

Mar. 31 2024

-0.41

-0.43

-0.52

Missed

-21.9

​​Dec. 31 2023

-0.44

-0.43

-0.36

Beat

16.5

Sep. 30 2023

-0.50

-0.47

-0.45

Beat

4.4​

Jun. 30 2023

-0.47

-0.45

-0.57

Missed

-27.7

Mar. 31 2023

-0.45

-0.43

-0.46

Missed

-7.5

This summary was machine generated May 28 at 12:32 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI